Cargando…

Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies

We report the design and synthesis of a series of dipeptide-type inhibitors with novel P3 scaffolds that display potent inhibitory activity against SARS-CoV 3CL(pro). A docking study involving binding between the dipeptidic lead compound 4 and 3CL(pro) suggested the modification of a structurally fl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thanigaimalai, Pillaiyar, Konno, Sho, Yamamoto, Takehito, Koiwai, Yuji, Taguchi, Akihiro, Takayama, Kentaro, Yakushiji, Fumika, Akaji, Kenichi, Chen, Shen-En, Naser-Tavakolian, Aurash, Schön, Arne, Freire, Ernesto, Hayashi, Yoshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115411/ https://www.ncbi.nlm.nih.gov/pubmed/23994330 http://dx.doi.org/10.1016/j.ejmech.2013.07.037

Ejemplares similares

Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study
por: Thanigaimalai, Pillaiyar, et al.
Publicado: (2013)

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
por: Konno, Sho, et al.
Publicado: (2013)

An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2016)

Reaction of indoles with aromatic fluoromethyl ketones: an efficient synthesis of trifluoromethyl(indolyl)phenylmethanols using K(2)CO(3)/n-Bu(4)PBr in water
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
por: Konno, Hiroyuki, et al.
Publicado: (2016)

Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor
por: Konno, Hiroyuki, et al.
Publicado: (2017)

Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant
por: Akaji, Kenichi, et al.
Publicado: (2008)

Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2017)

Recent discovery and development of inhibitors targeting coronaviruses
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19
por: Manickam, Manoj, et al.
Publicado: (2021)

Novel Treatment Setup for Urethral Cancer: Use of the Prone Technique for Radiotherapy of the Penis
por: Naser-Tavakolian, Aurash, et al.
Publicado: (2018)

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
por: Kronenberger, Thales, et al.
Publicado: (2023)

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor
por: Yoshizawa, Shin-ichiro, et al.
Publicado: (2020)

The recent outbreaks of human coronaviruses: A medicinal chemistry perspective
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice
por: Hess, Cornelius, et al.
Publicado: (2016)

Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor
por: Ohnishi, Kouji, et al.
Publicado: (2019)

Inhibitor induced conformational changes in SARS-COV-2 papain-like protease
por: Ferreira, Glaucio Monteiro, et al.
Publicado: (2022)

Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
por: Shimamoto, Yasuhiro, et al.
Publicado: (2015)

The Activation of GPR27 Increases Cytosolic L-Lactate in 3T3 Embryonic Cells and Astrocytes
por: Dolanc, Dorian, et al.
Publicado: (2022)

Iodine-catalyzed electrophilic substitution of indoles: Synthesis of (un)symmetrical diindolylmethanes with a quaternary carbon center
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2021)

N(α)-1, 3-Benzenedicarbonyl-Bis-(Amino Acid) and Dipeptide Candidates: Synthesis, Cytotoxic, Antimicrobial and Molecular Docking Investigation
por: Naglah, Ahmed M, et al.
Publicado: (2021)

Simultaneous Bladder Drainage via Suprapubic and Urethral Catheters: Which Drains More Completely and Why?
por: Naser-Tavakolian, Aurash, et al.
Publicado: (2023)

Robotic bilateral nephrectomy for large polycystic kidney disease
por: Masterson, John M., et al.
Publicado: (2023)

Novel Leu-Val Based Dipeptide as Antimicrobial and Antimalarial Agents: Synthesis and Molecular Docking
por: Ezugwu, James A., et al.
Publicado: (2020)

Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease
por: Akaji, Kenichi, et al.
Publicado: (2020)

Synthesis, Docking, Computational Studies, and Antimicrobial Evaluations of New Dipeptide Derivatives Based on Nicotinoylglycylglycine Hydrazide
por: Khalaf, Hemat S., et al.
Publicado: (2020)

New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors
por: Regnier, Thomas, et al.
Publicado: (2009)

Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease
por: Ramajayam, R., et al.
Publicado: (2010)

Machine learning prediction of 3CL(pro) SARS-CoV-2 docking scores
por: Bucinsky, Lukas, et al.
Publicado: (2022)

QSAR and molecular docking studies of isatin and indole derivatives as SARS 3CL(pro) inhibitors
por: Soleymani, Niousha, et al.
Publicado: (2023)

Frequency of dipeptides and antidipeptides
por: Carugo, Oliviero
Publicado: (2013)

6-(Ar)Alkylamino-Substituted Uracil Derivatives: Lipid Mimetics with Potent Activity at the Orphan G Protein-Coupled Receptor 84 (GPR84)
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2018)

Discovery of Polyphenolic Natural Products as SARS-CoV-2 M(pro) Inhibitors for COVID-19
por: Krüger, Nadine, et al.
Publicado: (2023)

Cyclic Dipeptides Formation From Linear Dipeptides Under Potentially Prebiotic Earth Conditions
por: Guo, Yeting, et al.
Publicado: (2021)

Self-assembling Fmoc dipeptide hydrogel for in situ 3D cell culturing
por: Liebmann, Thomas, et al.
Publicado: (2007)

Synthesis of glutamic acid and glutamine peptides possessing a trifluoromethyl ketone group as SARS-CoV 3CL protease inhibitors
por: Sydnes, Magne O., et al.
Publicado: (2006)

Structural Requirements of N-alpha-Mercaptoacetyl Dipeptide (NAMdP) Inhibitors of Pseudomonas Aeruginosa Virulence Factor LasB: 3D-QSAR, Molecular Docking, and Interaction Fingerprint Studies
por: Velázquez-Libera, José Luis, et al.
Publicado: (2019)

COMBINATION OF SALTS AND PROTEINS : III. THE COMBINATION OF CuCl(2), MgCl(2), CaCl(2), AlCl(3), LaCl(3), KCl, AgNO(3)AND Na(2)SO(4)WITH GELATIN.
por: Northrop, John H., et al.
Publicado: (1928)

Involvement of GPR17 in Neuronal Fibre Outgrowth
por: Braune, Max, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rnt2o1odkfb5d4m2i14qh1g1ar